Expression of DNA Topoisomerase IIα in Thyroid Neoplasia
- 1 April 2000
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (4) , 396-400
- https://doi.org/10.1038/modpathol.3880066
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Quantitative Immunocytochemical Assays of Topoisomerase II in Lung Adenocarcinoma Cell Lines : Correlation to topoisomerase IIα content and topoisomerase II catalytic activityActa Oncologica, 1996
- A Novel Panel of Antibodies that Segregates Immunocytochemically Poorly Differentiated Carcinoma from Undifferentiated Carcinoma of the Thyroid GlandThe American Journal of Surgical Pathology, 1994
- Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: Correlation with clinico-pathological featuresVirchows Archiv, 1993
- Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implicationsWorld Journal of Surgery, 1992
- Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase IIJournal of Molecular Biology, 1992
- DNA Topoisomerases as Anticancer Drug TargetsPublished by Elsevier ,1990
- Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase IIBiochemistry, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.Proceedings of the National Academy of Sciences, 1988
- Chemotherapy for thyroid cancerRadiotherapy and Oncology, 1987